Board of Directors
- Daniel Amburn, Genmab, Board Chairman
- Tom Adams, Pairwise
- Tom Alapaattikoski, Brinter
- Harold Alterson, Humacyte
- Andrew Barnhill, IQVIA
- Sinu Bhandaru, Precision BioSciences
- Christopher Capel, Smith Anderson
- Leonardo Costa Siqueira, Novo Nordisk
- Matthew Cooke, Davis Moore
- Drew Cutshaw, Pappas Capital
- Lisa Davidson, Syneos Health
- Neal Fowler, Pathalys Pharma
- Kent Geer, MED1 Ventures
- Matt Goodrich, Davis Moore
- Rachel Hardin, SAS
- Nikki Heron, Tavros Therapeutics
- Patrick Jordan, Mycovia
- Lauren Joyce, EisnerAmper LLP
- Toni Lockett, PricewaterhouseCoopers
- Michelle Logan, Thermo Fisher Scientific/Patheon
- Bennett Love, BioKier
- John Mikszta, BD
- Julie Broadus Meigs, Womble Bond Dickinson
- Dan Peterson, Cook Medical
- Buck Phillips, Ribometrix
- Dave Posehn, Pfizer
- Russ Read, National Center for the Biotechnology Workforce
- Joe Ruiz, Epigenos Biosciences
- Marlene Sanders, Merck & Co.
- Kseniya Simpson, Hatteras Venture Partners
- Heather Smith, Novonesis
- Maria Stauffer, Alexandria Real Estate Equities
- Christine Vannais, FUJIFILM Diosynth Biotechnologies
- Daniel VonDielingen, Lilly RTP
- Peter Wirth, RTI International
October 2024